Abstract:Cancer metastasis is the main cause of death (90%), and only recently we have gained some insight into the mechanisms by which metastatic cells arise from primary tumors and target to specific organs. Cysteine X Cysteine (CXC) chemokine receptor 4 (CXCR4), initially linked with leukocyte trafficking, is overexpressed in various tumors and mediates homing of tumor cells to distant sites expressing its cognate ligand CXCL12. Therefore, identification of CXCR4 inhibitors has great potential to abrogate tumor metastasis. In this study, we demonstrated that xanthohumol (XN), a prenylflavonoid derived from the female flowers of the hops plant (Humulus lupulus. L), suppressed CXCR4 expression in various cancer cell types in a concentration- and time-dependent manner. Both proteasome and lysosomal inhibitors had no effect to prevent the XN-induced downregulation of CXCR4, suggesting that the inhibitory effect of XN was not due to proteolytic degradation but occurred at the transcriptional level. Electrophoretic mobility shift assay and chromatin immunoprecipitation assay further confirmed that XN could block endogenous activation of nuclear factor kappa B, a key transcription factor regulates the expression of CXCR4 in cancer cells. Consistent with the above molecular basis, XN abolished cell invasion induced by CXCL12 in both breast and colon cancer cells. Interestingly, although co-exist in hops, XN is the only isoform that exhibited the inhibitory effect on the expression of CXCR4 compared with other isomers, isoxanthohumol and 8-prenylnaringenin. Together, our results suggested that XN, as a novel inhibitor of CXCR4, could be a promising therapeutic agent contributed to cancer treatment. Keywords: CXCL12, CXCR4, invasion, metastasis, xanthohumol, tumor, matrix metalloproteases, malignant disease, chemokines, leukocyte trafficking, antagonists, hop compounds, prenylflavonoid, anti-proliferative activity, carcinogens

New prenylchalcones from the hops of Humulus lupulus.

Novel Prenylated Bichalcone and Chalcone from Humulus Lupulus and Their Quinone Reductase Induction Activities

A Novel Prenylchalcone From Humulus Lupulus

Synthesis and Antiproliferative Activity of Prenylated Chalcone Mannich Base Derivatives

Generation of xanthohumol derivatives through fungi-mediated biotransformation

Isolation and Identification of Prenylflavonoids from Humulus Lupulus

Synthesis and Anti-Cancer Activity Evaluation of Novel Prenylated and Geranylated Chalcone Natural Products and Their Analogs.

Anti-inflammatory and Antiproliferative Prenylated Chalcones from Hedysarum Gmelinii

Synthesis and Antioxidant Evaluation of Desmethylxanthohumol Analogs and Their Dimers.

A new formylated chalcone from Humulus lupulus with protective effect on HUVECs injury by angiotensin II

Synthesis and cytotoxicity of chalcones and 5-deoxyflavonoids.

A New Dihydrochalcone from Humulus Scandens

Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets

Naturally occurring prenylated chalcones from plants: structural diversity, distribution, activities and biosynthesis

Xanthohumol, a Prenylated Chalcone Derived from Hops, Suppresses Cancer Cell Invasion Through Inhibiting the Expression of CXCR4 Chemokine Receptor.

Pharmacological Profile of Xanthohumol, a Prenylated Flavonoid from Hops (humulus Lupulus)

Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells

Increasing Structural Diversity of Prenylated Chalcones by Two Fungal Prenyltransferases.

Synthesis, SAR and Biological Evaluation of Natural and Non-natural Hydroxylated and Prenylated Xanthones As Antitumor Agents

Biotransformation of Xanthohumol by Entomopathogenic Filamentous Fungi

Novel 2′-Hydroxylfurylchalcones: Synthesis and Biological Activity